{"id":"W1558836596","doi":"10.1002/jcph.326","title":"Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: A randomized, multicenter, open‐label, phase I study","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Pasireotide; Acromegaly; Medicine; Tolerability; Pharmacokinetics; Adverse effect; Pharmacodynamics; Internal medicine; Octreotide; Gastroenterology; Somatostatin; Randomized controlled trial; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004661925,0.0002236102,0.001728303,0.0001285418,0.00005918337,0.000009356992,0.0003463454,0.0000606037,0.000141807],"category_scores_gemma":[0.0003878415,0.0001174809,0.0001182404,0.000143711,0.0004244827,0.0001528405,0.0001713443,0.0005914487,0.00000305672],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000253164,"about_ca_system_score_gemma":0.00009888774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000529856,"about_ca_topic_score_gemma":0.00001466272,"domain_scores_codex":[0.9955481,0.001831422,0.001855516,0.0001999313,0.0003050383,0.0002600398],"domain_scores_gemma":[0.9961987,0.001984964,0.001098987,0.0001695726,0.0002918919,0.0002559541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5694543,0.02492893,0.3913036,0.00003822471,0.001948,0.00007356095,0.0003112492,0.00003983783,0.0001074262,0.000004991312,0.0005585377,0.01123133],"study_design_scores_gemma":[0.88786,0.009566047,0.09560777,0.00007236678,0.003397952,0.0000207898,0.00009863347,0.002526966,0.00007975684,0.00007154977,0.0005816503,0.0001165258],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954878,0.0004110381,0.0001656662,0.001000082,0.0006084833,0.00211784,0.00001807967,0.000004815025,0.0001861697],"genre_scores_gemma":[0.996412,0.001678413,0.0002794444,0.00139824,0.000160763,0.000009614355,0.000007246289,0.00002143002,0.00003278508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3184057,"threshold_uncertainty_score":0.479073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03529810473432504,"score_gpt":0.4234314662478706,"score_spread":0.3881333615135455,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}